Concepedia

Nishant Mohan

NM

Statistics

Publications

29

Citations

1.4K

H-Index

19

Active since

2008

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

University of South Carolina

Medical University of South Carolina

National Cancer Institute

Nishant Mohan is an author at Center for Drug Evaluation and Research specializing in oncology, molecular oncology, and pharmacology.

Publications per year

2008–2024

29

Publications

29

Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma

Matija Snuderl, Ana Batista, Nathaniel D. Kirkpatrick et al. · Cell · 2013 · 259 citations · Full text

, , +14

Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers

Nishant Mohan, Jiangsong Jiang, Milos Dokmanovic et al. · Antibody Therapeutics · 2018 · 154 citations · Full text

, , +17

Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice

M. Khair ElZarrad, Partha Mukhopadhyay, Nishant Mohan et al. · PLoS ONE · 2013 · 136 citations · Full text

, , +17

Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes

Nishant Mohan, Yi Shen, Yukinori Endo et al. · Molecular Cancer Therapeutics · 2016 · 130 citations · Full text

, , +17

Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1<sup>+</sup>triple negative breast cancer cells

Nishant Mohan, Salman B. Hosain, Jun Zhao et al. · OncoImmunology · 2019 · 72 citations · Full text

, , +17

1–5 of 29